Lurasidone Hydrochloride
Showing 26 - 50 of 1,837
Breast Cancer Trial in Beijing (Mitoxantrone HCl liposome, Capecitabine)
Not yet recruiting
- Breast Cancer
- Mitoxantrone hydrochloride liposome
- Capecitabine
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Dec 1, 2023
Analyze Cardiometabolic Profile Changes to Switch to Lurasidone
Terminated
- Schizophrenia
-
Málaga, Andalucia, Spain
- +9 more
Sep 20, 2022
Non Small Cell Lung Cancer, Propranolol Trial (Propranolol HCl, Sintilimab, Chemotherapy)
Not yet recruiting
- Non Small Cell Lung Cancer
- Propranolol
- Propranolol hydrochloride
- +2 more
- (no location specified)
Jul 31, 2023
Platinum-resistant Ovarian Cancer Trial in Shanghai (Oral Topotecan Combined With Anlotinib)
Not yet recruiting
- Platinum-resistant Ovarian Cancer
- Oral Topotecan Combined With Anlotinib
-
Shanghai, ChinaXinhua Hospital Affiliated to Shanghai Jiaotong University Schoo
Feb 12, 2023
Associated With Cardiomyopathy and Heart Failure After Cancer
Recruiting
- Hodgkin Lymphoma in Remission
- +6 more
- Assessment of Therapy Complications
- +3 more
-
Birmingham, Alabama
- +78 more
Jan 11, 2023
Myelofibrosis Trial in Changsha (Jaktinib Hydrochloride Tablets)
Not yet recruiting
- Myelofibrosis
- Jaktinib Hydrochloride Tablets
-
Changsha, Hunan, ChinaThe Third Hospital of Changsha
Nov 9, 2023
Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Intraductal Papillary-Mucinous Tumor Trial in
Active, not recruiting
- Pancreatic Acinar Cell Carcinoma
- +8 more
- 3-Dimensional Conformal Radiation Therapy
- +8 more
-
Mobile, Alabama
- +697 more
Nov 16, 2022
Nausea and Vomiting Trial in Xi'an (Palonosetron HCl capsules)
Recruiting
- Nausea and Vomiting
- Palonosetron hydrochloride capsules
-
Xi'an, Shaanxi, ChinaThe First Affiliated Hospital, the Air Force Medical University
Jan 18, 2023
Pancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma Trial in United States (Fluorouracil, Gemcitabine Hydrochloride,
Completed
- Pancreatic Adenocarcinoma
- Resectable Pancreatic Carcinoma
- Fluorouracil
- +5 more
-
Birmingham, Alabama
- +806 more
Oct 18, 2022
Lymphoma, Solid Tumors Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome)
Recruiting
- Lymphoma, Solid Tumors
- Mitoxantrone Hydrochloride Liposome
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 14, 2022
Oxycodone Sustained-release Tablets for Moderate to Severe
Recruiting
- Cancer Pain
- +2 more
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Jul 24, 2023
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid
Active, not recruiting
- Acute Myeloid Leukemia
- +9 more
- Carboplatin
- +3 more
-
Los Angeles, California
- +5 more
Jan 27, 2023
Knee Osteoarthritis Trial in United Kingdom (Liposomal bupivacaine, Bupivacaine HCl)
Completed
- Knee Osteoarthritis
- Liposomal bupivacaine
- Bupivacaine hydrochloride
-
Birmingham, United Kingdom
- +10 more
Nov 3, 2022
Male Breast Cancer, Recurrent Melanoma, Stage IV Breast Cancer Trial in Columbus (propranolol HCl, Correlative Studies)
Completed
- Male Breast Cancer
- +7 more
- propranolol hydrochloride
- Correlative Studies
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 4, 2022
Relapsing Multiple Sclerosis Trial in Beijing (Mitoxantrone Hydrochloride Liposome Injection)
Not yet recruiting
- Relapsing Multiple Sclerosis
- Mitoxantrone Hydrochloride Liposome Injection
-
Beijing, Beijing, ChinaXuanwu Hospital Capital Medical University
Aug 9, 2022
Head and Neck Squamous Cell Carcinoma, Pain, Stomatitis Trial in Buffalo (Gabapentin, Methadone Hydrochloride, Oxycodone
Completed
- Head and Neck Squamous Cell Carcinoma
- +2 more
- Gabapentin
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Metastatic Urothelial Carcinoma, Transitional Cell Carcinoma, Unresectable Transitional Cell Carcinoma Trial in Houston
Active, not recruiting
- Metastatic Urothelial Carcinoma
- +2 more
- Doxorubicin Hydrochloride
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
Anorexia, Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Houston (Anamorelin Hydrochloride, Placebo,
Active, not recruiting
- Anorexia
- +8 more
- Anamorelin Hydrochloride
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Third Molar Extraction Trial in São Paulo (FDC of etoricoxib + cyclobenzaprine + etoricoxib , etoricoxib 90 mg (Arcoxia®) +FDC ,
Not yet recruiting
- Third Molar Extraction
- FDC of etoricoxib + cyclobenzaprine + etoricoxib placebo
- +2 more
-
São Paulo, SP, BrazilEurofarma Laboratorios S.A
Jan 11, 2023
Solid Tumor Trial in Jacksonville, Rochester (Laboratory Biomarker Analysis, Pazopanib Hydrochloride, Pharmacological Study)
Active, not recruiting
- Solid Neoplasm
- Laboratory Biomarker Analysis
- +2 more
-
Jacksonville, Florida
- +1 more
Jan 25, 2023
Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in United
Recruiting
- Advanced Lung Non-Small Cell Carcinoma
- +2 more
- Osimertinib
- Telaglenastat Hydrochloride
-
Birmingham, Alabama
- +10 more
Jan 25, 2023
Schizophrenia Trial in China (Lurasidone tablets, Risperidone tablets)
Completed
- Schizophrenia
- Lurasidone tablets
- Risperidone tablets
-
Beijing, Beijing, China
- +14 more
Nov 3, 2019
Parkinson Disease Trial (Ambroxol Hydrochloride (420mg), Placebo)
Not yet recruiting
- Parkinson Disease
- Ambroxol Hydrochloride (420mg)
- Placebo
- (no location specified)
Mar 9, 2023
Breast Reduction Trial in Rochester (Bupivacaine Hydrochloride, Liposomal Bupivacaine)
Not yet recruiting
- Breast Reduction
- Bupivacaine Hydrochloride
- Liposomal Bupivacaine
-
Rochester, MinnesotaMayo Clinic Minnesota
May 26, 2023